MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Rx and OTC acne/rosacea medications

Cosmederm Technologies
Rx and OTC acne medications

Full description

Our products are formulated to be the most active Rx and OTC products available. Using our patented anti-irritant technology, Cosmederm-7, we have formulated products that are stronger than the current state of the art but are non-irritating.

We have a potential Rx acne product that contains 25% azelaic acid that is more active and significantly less irritating than current Rx products containing 20% azelaic acid (e.g. Azelex).

We have a potential Rx rosacea product that contains 20% azelaic acid that is more active and significantly less irritating than current Rx products containing 15% azelaic acid (e.g. Finacea)

Our OTC acne products include a lotion formulated 10% azelaic acid and 2% salicylic acid and Cosmederm-7 for maximum potency with no irritation and a spot treatment gel that includes 15% azelaic acid and 2% salicylic acid.

Our unique proprietary information allows us to formulate our products with lower pH levels for maximum penetration and efficacy.  Further, azelaic acid has a number of additional benefits over traditional acne medications such as anti-aging and skin-lightening properties to remedy the long term aesthetic effects acne can have on skin.

Development status

Registered

Patent information

 Patented in all major markets.

Type of business relationship sought

We are amenable to a number of business relationships including acquisition, licensing, private labeling or distribution.

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us